The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

Viral Infections

Filter Newest Oldest Showing 1-7 of 7 results
Original Article / VOLUME 1, ISSUE 2, AUGUST 2019

Ombitasvir/ Paritaprevir/ Ritonavir + Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience

Bilgehan Aygen and others

About 170-200 million people are known to be infected with the hepatitis C virus (HCV) worldwide. Chronic hepatitis C (CHC) infection carries risks of hepatic fibrosis, cirrhosis, portal hypertension, liver failure, and hepatocellular carcinoma (HCC) (1-4). Chronic HCV infection is an important health problem in Turkey (5-10). In Turkey, among HCV infections, genotype 1b was reported to be the most common one (90%), while [...] Read More

Case Report / VOLUME 1, ISSUE 3, DECEMBER 2019

A Severe Sight-threatening Complication of Herpes Zoster Ophthalmicus: Orbital Apex Syndrome

Sumru Onal and others

Varicella-zoster virus (VZV) is found in worldwide distribution and can lead to two distinct viral syndromes. Primary infection occurs as varicella and is a contagious and usually benign childhood disease. Herpes zoster (HZ) presents as unilateral pain in a dermatomal distribution accompanied by a vesicular rash. Herpes zoster generally occurs in older adults and results from the reactivation of latent VZV […] Read More

Case Report / VOLUME 5, ISSUE 1, MARCH 2023

Four Human Mpox Cases from Turkey

Emine Coşkun and others

With the reports of patients with mpox (formerly monkeypox) outside Africa in April 2022, a second epidemic fear emerged around the world following the coronavirus disease 2019. From the onset of the mpox outbreak as of December 25, 2022, (...) Read More

Original Article / VOLUME 5, ISSUE 3, SEPTEMBER 2023

Bibliometric Analysis of the Publications on Middle East Respiratory Syndrome Coronavirus Published Between 2012-2022

Sevil Alkan and Esra Gürbüz

Middle East Respiratory Syndrome (MERS) is a viral respiratory infection caused by the MERS coronavirus (MERS-CoV) from the Coronaviridae family. MERS coronavirus was first identified as the etiologic agent from a patient living in Saudi Arabia in 2012, and it is the sixth human coronavirus . After the first case, the infection was detected in Bahrain, Iran, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, the United Arab Emirates, and Yemen. So far, all MERS-CoV cases worldwide have been associated with a travel history (...) Read More

Review Article / VOLUME 5, ISSUE 4, DECEMBER 2023

New Treatment Options in Chronic Hepatitis B: How Close Are We to Cure?

Pınar Korkmaz and others

Hepatitis B virus (HBV) infection is the leading cause of chronic liver disease worldwide. HBV-infected patients are at risk of developing liver cirrhosis and hepatocellular carcinoma (HCC) for life. Today, pegylated interferon (Peg-IFN) and nucleos(t)ide analogues (NAs) are used in the treatment of patients with chronic hepatitis B (CHB). Both treatment options have limitations. Read More